BIOTECHNOLOGY VALUE FUND L P

Holdings History for Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value
Latest Disclosed Shares Owned: 2,560,916 shares
Security Ownership %: 4.1%

BVF PARTNERS L P/IL ownership in Protagonist Therapeutics, Inc Common Stock, $0.00001 par value (PTGX)

14 Nov 2025 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,560,916 shares of Protagonist Therapeutics, Inc Common Stock, $0.00001 par value (PTGX). This represents 4.1% ownership of the company. In their previous filing dated 16 Jun 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 3,211,041 shares, indicating a decrease of +20%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	4.1%	-22%	$170,121,650	2,560,916	-650,125	-20%	$66.43	13G/A	30 Sep 2025	14 Nov 2025, 16:17
BVF PARTNERS L P/IL	5.2%		$147,129,899	3,211,041			$45.82	13G	09 Jun 2025	16 Jun 2025, 17:30